Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Inovio Pharmaceuticals (INO) shares

Learn how to easily invest in Inovio Pharmaceuticals shares.

Inovio Pharmaceuticals Inc is a biotechnology business based in the US. Inovio Pharmaceuticals shares (INO) are listed on the NASDAQ and all prices are listed in US Dollars. Inovio Pharmaceuticals employs 317 staff and has a trailing 12-month revenue of around USD$1.6 million.

Compare online trading platforms

How has Coronavirus impacted Inovio Pharmaceuticals's stock price?

Since the stock market crash in March caused by coronavirus, Inovio Pharmaceuticals's stock price has had significant negative movement.

Its last market close was $1.79, which is 52.20% down on its pre-crash value of $3.745 and 75.42% down on the lowest point reached during the March crash when the stocks fell as low as $3.14.

If you had bought $1,000 worth of Inovio Pharmaceuticals stocks at the start of February 2020, those stocks would have been worth $1,693.07 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $457.79.

Is it a good time to buy Inovio Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Inovio Pharmaceuticals shares at a glance

Information last updated 2022-06-27.
Latest market close$1.79
52-week range$1.38 - $9.96
50-day moving average $2.17
200-day moving average $4.58
Wall St. target price$5.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.54

Inovio Pharmaceuticals stock price (NASDAQ:INO)

Use our graph to track the performance of INO stocks over time.

Inovio Pharmaceuticals price performance over time

Historical closes compared with the close of $1.79 from 2022-06-29

1 week (2022-06-23) -10.95%
1 month (2022-05-26) N/A
3 months (2022-03-30) -50.96%
6 months (2021-12-27) -68.71%
1 year (2021-06-30) -80.69%
2 years (2020-06-30) -93.36%
3 years (2019-06-28) 2.94
5 years (2017-06-30) 7.84

Inovio Pharmaceuticals financials

Revenue TTM $1.6 million
Gross profit TTM $-247,465,566
Return on assets TTM -36.4%
Return on equity TTM -70.1%
Profit margin 0%
Book value $1.57
Market capitalisation $446.6 million

TTM: trailing 12 months

Inovio Pharmaceuticals share dividends

We're not expecting Inovio Pharmaceuticals to pay a dividend over the next 12 months.

Have Inovio Pharmaceuticals's shares ever split?

Inovio Pharmaceuticals's shares were split on a 1:4 basis on 5 June 2014. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Inovio Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Inovio Pharmaceuticals shares which in turn could have impacted Inovio Pharmaceuticals's share price.

Inovio Pharmaceuticals share price volatility

Over the last 12 months, Inovio Pharmaceuticals's shares have ranged in value from as little as $1.38 up to $9.96. A popular way to gauge a stock's volatility is its "beta".

INO.US volatility(beta: 0.82)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inovio Pharmaceuticals's is 0.8162. This would suggest that Inovio Pharmaceuticals's shares are less volatile than average (for this exchange).

Inovio Pharmaceuticals overview

Inovio Pharmaceuticals, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp. , AstraZeneca, Beijing Advaccine Biotechnology Co. , Ltd.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

  • Bajaj Finserv Securities review

    Bajaj Finserv offers personalised investment solutions to meet your trading needs.

  • Axis Direct review

    Axis Direct offers a 3-in-1 trading account to help you diversify your portfolio.

  • How India will be investing in 2022

    Finder’s Retail Investor Sentiment Report polled 39,573 Internet users across 26 countries to see how they’ll be investing their money in 2022.

  • How to invest in the S&P 500 from India

    Find out the different ways you can invest in the S&P 500, one of the world’s most popular stock market indices.

  • ETFs vs index funds

    Find out about what ETFs and index funds are, their key similarities and differences, as well as how to invest in these passive funds.

  • How to invest in gold ETFs in India

    Find out about gold ETFs, what influences their prices, how you can trade them and whether they could be worth your weight in gold.

  • How to invest money

    Learn the basics of what it takes for novices to get started in the investment world in India, including an overview of your options and what to watch out for.

  • How to buy N/A (N/A) shares

    Steps to owning and managing N/A, with 24-hour and historical pricing before you buy.

  • How to buy N/A (N/A) shares

    Steps to owning and managing N/A, with 24-hour and historical pricing before you buy.

  • How to invest in oil in India

    Learn about the four options available to buy and sell this slippery commodity — as well as pros and cons.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy Policy and Terms.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site